Phase II/III Study of the Safety and Effectiveness of HRIG With Active Rabies Vaccine in Healthy Subjects
Clinical trial NCT02040090 · COMPLETED
Trial details
- NCT number
- NCT02040090
- Sponsor
- Kamada, Ltd.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2014-08-01
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.